Duggans abandon scheme, give $48.8 million in AbbVie stock directly to Scientology - 2019-10-18
Two years ago, we told you that before splitting up, Scientology's richest couple Bob and Trish Duggan set aside $59 million in stock from the pharmaceutical giant AbbVie, maker of Humira, the most profitable drug in the world, so that it would generate about $2.9 million in revenue each year which they planned to grant to various Scientology initiatives.
As long as AbbVie stock continued to keep its value, Scientology would have a reliable source of about $2.9 million a year in perpetuity. At least, that was the plan.
The AbbVie stock was deposited in the foundation in the last week of 2015, too late to show any disbursements from revenue that year. And so for the last two years we've been waiting patiently for the foundation to reveal what it did in tax year 2016, and to show how it distributed any grants to Scientology.